Sankar D Navaneethan

9PUBLICATIONS
30CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Epidemiological modellingMolecular targetsBehavioural epidemiologySport and exercise nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 02, 2026
Executive Summary of the ASN Kidney Health Guidance on the Cardiovascular‑Kidney‑Metabolic Syndrome.

|Sep 02, 2026
ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome.

|Jun 05, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

|Mar 30, 2026
Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease.

Kavya Rajan, Arjun Krishen Jutley, Michael W Holliday

|Nov 12, 2025
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study.

David C Wheeler, Kevin M Pantalone, Lixin Guo

|Jul 27, 2021
Management of type 2 diabetes in chronic kidney disease.

Jefferson L Triozzi, L Parker Gregg, Salim S Virani

Pageof 2

Frequent Collaborators

3 joint publications

Amy K Mottl

2 joint publications

Michael W Holliday

2 joint publications

Brian S Rifkin

1 joint publications

Jefferson L Triozzi